drugset / Trial / NCT00697242
Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older Adults
RandomizedParallel-groupTriple-blindPrevention
Summary
In the present study the immunogenicity, reactogenicity and safety of recombinant hepatitis B vaccines with and without MPL will be evaluated in older healthy subjects
Timeline
- Start
- 1994-01
- Primary completion
- 1995-11
- Completion
- 1995-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Engerix-B | Vaccine | — | Intramuscular |
| Subject | Recombinant HBsAg | Vaccine | — | Intramuscular |